Correlation between Peripheral Blood PLR with Treg, Th17 in Newly Diagnosed Multiple Myeloma and Its Influence on Prognosis.
10.19746/j.cnki.issn.1009-2137.2023.06.024
- Author:
Na QIN
1
;
Rui Ting FENG
2
;
Xuan WANG
1
;
Shu-Xia GUO
3
,
4
Author Information
1. Department of Hematology, The Fifth Clinical Medical College of Henan University of Chinese Medicine(Zhengzhou People's Hospital), Zhengzhou 450003, Henan Province, China.
2. Translational Medicine Center, The Fifth Clinical Medical College of Henan University of Chinese Medicine(Zhengzhou People's Hospital), Zhengzhou 450003, Henan Province, China.
3. Department of Hematology, The Fifth Clinical Medical College of Henan University of Chinese Medicine(Zhengzhou People's Hospital), Zhengzhou 450003, Henan Province, China,Email: guosx118@
4. com.
- Publication Type:Journal Article
- Keywords:
Th17;
Treg;
clinical features;
newly diagnosed multiple myeloma;
platelet/lymphocyte ratio;
prognosis
- MeSH:
Humans;
Multiple Myeloma/diagnosis*;
Blood Platelets;
T-Lymphocytes, Regulatory;
Prognosis;
Th17 Cells;
Retrospective Studies
- From:
Journal of Experimental Hematology
2023;31(6):1757-1763
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the correlation of peripheral blood platelet/lymphocyte ratio (PLR) with Treg and Th17 and its influence on prognosis in newly diagnosed multiple myeloma (MM).
METHODS:One hundred thirty-five newly diagnosed multiple myeloma patients admitted to the Department of Hematology of Zhengzhou People's Hospital from June 2015 to October 2022 were selected as MM group. Clinical data included sex, age, immune typing, ISS stage, blood calcium (Ca), albumin (ALB), hemoglobin (Hb), PLR, LDH, β2 microglobulin (β2-MG), Treg and Th17 levels. Sixty healthy volunteers who underwent physical examination in our hospital during the same period were selected as the control group. PLR, Treg and Th17 levels in MM group and control group were compared. Pearson was used to analyze the correlation between PLR and Treg, Th17. The relationship between MM patients with different PLR and clinical features and prognosis was analyzed.
RESULTS:The PLR and Th17 of MM patients were significantly higher than that of control group, and Treg was significantly lower than that of control group (P<0.05). In MM patients, PLR was negatively correlated with Treg (r=-0.616), and PLR was positively correlated with Th17 (r=0.555). Using mean PLR=132.72 as the boundary, 135 MM patients were divided into high PLR group (n=54) and low PLR group (n=81). In MM patients with high PLR, ISS stage, ALB and Treg were significantly higher than those in low PLR group, while Th17 was significantly lower than those in low PLR group (P<0.05). By univariate and COX regression analysis, PLR was an independent prognostic risk factor for newly diagnosed MM patients (P<0.05). MM patients with high PLR had better PFS and OS, and the difference was statistically significant compared with MM patients with low PLR (P<0.05). 65 patients admitted from June 2015 to December 2018 were used as the training set, and 70 patients admitted from January 2019 to October 2022 were used as the validation set. The OS of MM patients with different PLR were compared respectively. The results showed that the conclusions of the training set and the validation set were consistent. PLR with high expression had higher OS (P<0.01).
CONCLUSION:PLR is correlated with Treg and Th17 in newly diagnosed MM patients, and high PLR has better prognosis. PLR can be used to evaluate the prognosis of MM patients.
